Effects of Losartan and Simvastatin on Monocyte-Derived Microparticles in Hypertensive Patients With and Without Type 2 Diabetes Mellitus

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725 · see citing works

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,320 · see citing works

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220 · see citing works

Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol

Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407 · see citing works

Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency

Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C. E., Ritz, E., & Zucchelli, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341502 · Cited by 1,743 · see citing works

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08090-x · Cited by 1,560 · see citing works

Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.

Jonasson, L., Holm, J., Skalli, O., Bondjers, G., & Hansson, G. K. (1986) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.6.2.131 · Cited by 1,329 · see citing works

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

Wilcox, J. N., Smith, K. M., Schwartz, S. M., & Gordon, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2839 · Cited by 1,214 · see citing works

National High Blood Pressure Education Program Working Group report on hypertension in diabetes

(1994) · Hypertension · doi:10.1161/01.hyp.23.2.145 · Cited by 1,004 · see citing works

Monocytes and Macrophages

Johnston, R. B. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803243181205 · Cited by 697 · see citing works

Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation: Effects of Short- and Long-Term Simvastatin Treatment

Ceriello, A., Taboga, C., Tonutti, L., Quagliaro, L., Piconi, L., Bais, B., Da Ros, R., & Motz, E. (2002) · Circulation · doi:10.1161/01.cir.0000027569.76671.a8 · Cited by 655 · see citing works

Leucocyte-endothelial interactions and regulation of leucocyte migration

Adams, D., & Shaw, S. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92029-x · Cited by 580 · see citing works

Progression, remission, regression of chronic renal diseases

Ruggenenti, P. L., Schieppati, A., & Remuzzi, G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04728-0 · Cited by 545 · see citing works

ENDOTHELIAL-LEUKOCYTE ADHESION MOLECULES IN HUMAN DISEASE

Bevilacqua, M. P., Nelson, R. M., Mannori, G., & Cecconi, O. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.361 · Cited by 456 · see citing works

Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy

Kjeldsen, S. E., Dahlöf, B., Devereux, R. B., Julius, S., Aurup, P., Edelman, J. M., Beevers, G., Fairé, U. D., Fyhrquist, F., Ibsen, H., et al. (2002) · JAMA · doi:10.1001/jama.288.12.1491 · Cited by 441 · see citing works

Angiotensin II Induces Monocyte Chemoattractant Protein-1 Gene Expression in Rat Vascular Smooth Muscle Cells

Chen, X.-L., Tummala, P. E., Olbrych, M. T., Alexander, R. W., & Medford, R. M. (1998) · Circulation Research · doi:10.1161/01.res.83.9.952 · Cited by 384 · see citing works

Simvastatin Reduces Expression of Cytokines Interleukin-6, Interleukin-8, and Monocyte Chemoattractant Protein-1 in Circulating Monocytes From Hypercholesterolemic Patients

Rezaie-Majd, A., Maca, T., Bucek, R. A., Valent, P., Müller, M. R., Husslein, P. W., Kashanipour, A., Minar, E., & Baghestanian, M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000022694.16328.cc · Cited by 380 · see citing works

Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide.

Satta, N., Toti, F., Feugeas, O., Bohbot, A., Dachary-Prigent, J., Eschwège, V., Hedman, H., & Freyssinet, J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.7.3245 · Cited by 372 · see citing works

Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

Uusitupa, M. I. J., NISKANEN, L. K., Siitonen, O., Voutilainen, E., & Py�r�l�, K. (1993) · Diabetologia · doi:10.1007/bf00401063 · Cited by 353 · see citing works

Simvastatin Lowers C-Reactive Protein Within 14 Days

Plenge, J. K., Hernandez, T. L., Weil, K. M., Poirier, P., Grunwald, G. K., Marcovina, S. M., & Eckel, R. H. (2002) · Circulation · doi:10.1161/01.cir.0000029743.68247.31 · Cited by 351 · see citing works

Monocyte adherence to human vascular endothelium

Beekhuizen, H., & van Furth, R. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.54.4.363 · Cited by 229 · see citing works

Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line.

Drake, T. A., Ruf, W., Morrissey, J. H., & Edgington, T. S. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.109.1.389 · Cited by 225 · see citing works

Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus

Nomura, S. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05551-7 · Cited by 224 · see citing works

Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes.

Remuzzi, A., Perico, N., Amuchastegui, C. S., Malanchini, B., Mazerska, M., Battaglia, C., Bertani, T., & Remuzzi, G. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v4140 · Cited by 216 · see citing works

Association Between Enhanced Soluble CD40L and Prothrombotic State in Hypercholesterolemia

Cipollone, F., Mezzetti, A., Porreca, E., Febbo, C. D., Nutini, M., Fazia, M. L., Falco, A., Cuccurullo, F., & Davı̀, G. (2002) · Circulation · doi:10.1161/01.cir.0000025419.95769.f0 · Cited by 215 · see citing works

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia

Ferro, D., Parrotto, S., Basili, S., Alessandri, C., & Violi, F. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00771-3 · Cited by 207 · see citing works

Statins as Potent Antiinflammatory Drugs

Lefer, D. J. (2002) · Circulation · doi:10.1161/01.cir.0000033635.42612.88 · Cited by 182 · see citing works

Significance of chemokines and activated platelets in patients with diabetes

Nomura, S., Shouzu, A., Omoto, S., Nishikawa, M., & Fukuhara, S. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01324.x · Cited by 180 · see citing works

Increased Levels of Soluble Adhesion Molecules in Type 2 (Non-Insulin Dependent) Diabetes mellitus Are Independent of Glycaemic Control

Steiner, M., Reinhardt, K. M., Krammer, B., Ernst, B., & Blann, A. D. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648993 · Cited by 175 · see citing works

Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus

Carmassi, F., Morale, M., Puccetti, R., Negri, F. D., Monzani, F., Navalesi, R., & Mariani, G. (1992) · Thrombosis Research · doi:10.1016/0049-3848(92)90068-l · Cited by 170 · see citing works

Microalbuminuria and coronary heart disease in NIDDM: an incidence study.

Mattock, M. B., Barnes, D. J., Viberti, G. C., Keen, H. I., Burt, D. J., Hughes, J. M., Fitzgerald, A. J., Sandhu, B. K., & Jackson, P. (1998) · Diabetes · doi:10.2337/diabetes.47.11.1786 · Cited by 162 · see citing works

Angiotensin-Converting Enzyme Inhibitors Downregulate Tissue Factor Synthesis in Monocytes

Napoleone, E., Santo, A. D., Camera, M., Tremoli, E., & Lorenzet, R. (2000) · Circulation Research · doi:10.1161/01.res.86.2.139 · Cited by 135 · see citing works

Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes

Cheetham, C., Collis, J. J., O’Driscoll, G., Stanton, K. G., Taylor, R. R., & GREEN, D. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00933-5 · Cited by 128 · see citing works

Effect of combining ACE inhibitor and statin in severe experimental nephropathy

Zoja, C., Corna, D., Rottoli, D., Cattaneo, D., Zanchi, C., Tomasoni, S., Abbate, M., & Remuzzi, G. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00332.x · Cited by 116 · see citing works

Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus

Omoto, S., Nomura, S., Shouzu, A., Nishikawa, M., Fukuhara, S., & Iwasaka, T. (2002) · Diabetologia · doi:10.1007/s00125-001-0772-7 · Cited by 113 · see citing works

Angiotensin II Induces Migration and Pyk2/Paxillin Phosphorylation of Human Monocytes

Kintscher, U., Wakino, S., Kim, S., Fleck, E., Hsueh, W. A., & Law, R. E. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.587 · Cited by 105 · see citing works

Inhibition of tissue-factor-mediated thrombin generation by simvastatin

Ferro, D., Basili, S., Alessandri, C., Cara, D., & Violi, F. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00291-9 · Cited by 103 · see citing works

Effect of Cilostazol on Soluble Adhesion Molecules and Platelet-derived Microparticles in Patients with Diabetes

Shouzu, A., Omoto, S., Hayakawa, T., Kagawa, H., Nishikawa, M., Inada, M., Fujimura, Y., Ikeda, Y., Fukuhara, S., & Nomura, S. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615217 · Cited by 102 · see citing works

Relationship Between Ethnicity and Glycemic Control, Lipid Profiles, and Blood Pressure During the First 9 Years of Type 2 Diabetes

Davis, T. M. E., Cull, C. A., Holman, R. R., & for the U.K. Prospective Diabetes Study (UKPDS) Group (2001) · Diabetes Care · doi:10.2337/diacare.24.7.1167 · Cited by 100 · see citing works

Immune Mechanisms of Atherosclerosis in Diabetes Mellitus

Lopes-Virella, M. F., & Virella, G. (1992) · Diabetes · doi:10.2337/diab.41.2.s86 · Cited by 90 · see citing works

E-Selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress

Cominacini, L., Pasini, A. F., Garbin, U., Campagnola, M., Davoli, A., Rigoni, A. M., Zenti, M. G., Pastorino, A. M., & Cascio, V. L. (1997) · Diabetologia · doi:10.1007/s001250050719 · Cited by 88 · see citing works

NIDDM is the Major Cause of Diabetic End-Stage Renal Disease: More Evidence From a Tri-Ethnic Community

Pugh, J. A., Medina, R., Cornell, J. C., & Basu, S. (1995) · Diabetes · doi:10.2337/diab.44.12.1375 · Cited by 79 · see citing works

Dysregulation of Calpain Proteolytic Systems Underlies Degenerative Vascular Disorders

Miyazaki, T., & Miyazaki, A. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17008 · Cited by 75 · see citing works

Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients

Fogari, R., Mugellini, A., Zoppi, A., Corradi, L., Preti, P. S., Lazzari, P., & Derosa, G. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02340-8 · Cited by 70 · see citing works

AT1-Receptor Antagonists Abolish Glomerular MCP-1 Expression in a Model of Mesangial Proliferative Glomerulonephritis

Wolf, G., Schneider, A., Helmchen, U. M., & Stahl, R. A. K. (1998) · Nephron Experimental Nephrology · doi:10.1159/000020513 · Cited by 60 · see citing works

Endotoxin enhances the expression of monocyte prothrombinase activity

Robinson, R., Worfolk, L. A., & Tracy, P. (1992) · Blood · doi:10.1182/blood.v79.2.406.406 · Cited by 55 · see citing works

Effect of losartan in aging-related endothelial impairment

Rajagopalan, S., Brook, R. D., Mehta, R. H., Supiano, M. A., & Pitt, B. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02297-4 · Cited by 51 · see citing works

Effect of simvastatin on monocyte adhesion molecule expression in patients with hypercholesterolemia

Junior, C. V. S., Yoshida, V. M., Venturinelli, M. L., D’Amico, É. A., Monteiro, H. P., Ramires, J. A. F., & da Luz, P. L. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00757-7 · Cited by 50 · see citing works

Procoagulant and profibrinolytic activities of cryopreserved human monocytes

Osnes, L., Westvik, Å.-B., & Kierulf, P. (1994) · Thrombosis Research · doi:10.1016/0049-3848(94)90166-x · Cited by 45 · see citing works

Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1

Jilma, B., Li‐Saw‐Hee, F. L., Wagner, O. F., Beevers, D. G., & Lip, G. Y. H. (2002) · Clinical Science · doi:10.1042/cs1030131 · Cited by 45 · see citing works

HMG-CoA Reductase Inhibitors Reduce Adhesion of Human Monocytes to Endothelial Cells

Teupser, D., Bruegel, M., Stein, O., Stein, Y., & Thiery, J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6066 · Cited by 39 · see citing works

Losartan in patients with type 2 diabetes and proteinuria: Observations from the RENAAL Study

Shahinfar, S., Dickson, T. Z., Ahmed, T., Zhang, Z., Ramjit, D. R., Smith, R. D., & Brenner, B. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.62.s82.13.x · Cited by 33 · see citing works

Angiotensin II AT1-Receptor Blockade Inhibits Monocyte Activation and Adherence in Transgenic (mRen2)27 Rats

Strawn, W. B., Gallagher, P. E., Tallant, E. A., Ganten, D., & Ferrario, C. M. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199903000-00001 · Cited by 33 · see citing works

Losartan Inhibits Cellular Uptake of Oxidized LDL by Monocyte-Macrophages from Hypercholesterolemic Patients

Hayek, T., Aviram, M., Heinrich, R., Sakhnini, E., & Keidar, S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2963 · Cited by 32 · see citing works

Simvastatin reduces plasma concentration of high-sensitivity C-reactive protein in type 2 diabetic patients with hyperlipidemia.

Lee, I., Sheu, W., Lin, S.-Y., Lee, W.-J., Song, Y.-M., & Liu, H.-C. (2002) · Journal of diabetes and its complications · doi:10.1016/s1056-8727(02)00184-8 · Cited by 19 · see citing works

Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology

Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R. G., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,106 · see citing works

Extracellular vesicles in coronary artery disease

Boulanger, C. M., Loyer, X., Rautou, P., & Amabile, N. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.7 · Cited by 510 · see citing works

Procoagulant Microparticles

Morel, O., Toti, F., Hugel, B., Bakouboula, B., Camoin‐Jau, L., Dignat‐George, F., & Freyssinet, J. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000246775.14471.26 · Cited by 461 · see citing works

Cellular microparticles: a disseminated storage pool of bioactive vascular effectors

Morel, O., Toti, F., Hugel, B., & Freyssinet, J. (2004) · Current Opinion in Hematology · doi:10.1097/01.moh.0000131441.10020.87 · Cited by 454 · see citing works

Microparticles: biomarkers and beyond

Burger, D. E., Schock, S., Thompson, C. S., Montezano, A. C. I., Hakim, A. M., & Touyz, R. M. (2012) · Clinical Science · doi:10.1042/cs20120309 · Cited by 359 · see citing works

Effect of Atorvastatin and Irbesartan, Alone and in Combination, on Postprandial Endothelial Dysfunction, Oxidative Stress, and Inflammation in Type 2 Diabetic Patients

Ceriello, A., Assaloni, R., Da Ros, R., Maier, A., Piconi, L., Quagliaro, L., Esposito, K., & Giugliano, D. (2005) · Circulation · doi:10.1161/01.cir.0000165070.46111.9f · Cited by 298 · see citing works

Extracellular Vesicles in Cardiovascular Disease

Jansen, F., Nickenig, G., & Werner, N. (2017) · Circulation Research · doi:10.1161/circresaha.117.310752 · Cited by 279 · see citing works

Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study

Amabile, N., Cheng, S. C., Renard, J. M., Larson, M. G., Ghorbani, A., McCabe, E. L., Griffin, G. K., Guérin, C. L., Ho, J. E., Shaw, S. Y., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu153 · Cited by 231 · see citing works

Endothelial Microparticle Formation by Angiotensin II Is Mediated via Ang II Receptor Type I/NADPH Oxidase/ Rho Kinase Pathways Targeted to Lipid Rafts

Burger, D. E., Montezano, A. C. I., Nishigaki, N., He, Y., Carter, A., & Touyz, R. M. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.222703 · Cited by 221 · see citing works

Leukocyte-Derived Microparticles in Vascular Homeostasis

Angelillo‐Scherrer, A. (2012) · Circulation Research · doi:10.1161/circresaha.110.233403 · Cited by 206 · see citing works

Function and role of microparticles in various clinical settings

Nomura, S., Ozaki, Y., & Ikeda, Y. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.06.006 · Cited by 191 · see citing works

The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases

Puddu, P., Puddu, G. M., Cravero, E., Muscari, S., & Muscari, A. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)70371-8 · Cited by 179 · see citing works

Vascular Inflammation and Endothelial Dysfunction in Experimental Hypertension

Savoia, C., Sada, L., Zezza, L., Pucci, L., Lauri, F. M., Befani, A., Alonzo, A., & Volpe, M. (2011) · International Journal of Hypertension · doi:10.4061/2011/281240 · Cited by 159 · see citing works

Renal and vascular hypertension-induced inflammation: role of angiotensin II

Ruiz‐Ortega, M., Esteban, V., Rupérez, M., Sánchez‐López, E., Rodríguez‐Vita, J., Carvajal, G., & Egido, J. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000203190.34643.d4 · Cited by 155 · see citing works

Role of inflammatory chemokines in hypertension

Mikolajczyk, T. P., Szczepaniak, P., Vidler, F., Maffia, P., Graham, G. J., & Guzik, T. J. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107799 · Cited by 155 · see citing works

Cell-Derived Microparticles in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-Analysis

Li, S., Jia, W. P., Zhang, C., Li, X., Meng, W., Mo, X., Zhang, Q., Liu, Q., Ren, K., Du, R., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452512 · Cited by 139 · see citing works

Microparticles: Key Protagonists in Cardiovascular Disorders

Amabile, N., Rautou, P., Tedgui, A., & Boulanger, C. M. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1267044 · Cited by 136 · see citing works

Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases

Chen, Y., Li, G., & Liu, M.-L. (2018) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2017.03.006 · Cited by 125 · see citing works

Plasmatic Level of Leukocyte-Derived Microparticles Is Associated With Unstable Plaque in Asymptomatic Patients With High-Grade Carotid Stenosis

Sarlon-Bartoli, G., Bennis, Y., Lacroix, R., Piercecchi-Marti, M. D., Bartoli, M. A., Arnaud, L., Mancini, J., Boudes, A., Sarlon, E., Thévenin, B., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.078 · Cited by 124 · see citing works

Role of microparticles in atherothrombosis

Leroyer, A. S., Tedgui, A., & Boulanger, C. M. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01957.x · Cited by 118 · see citing works

Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells

Suades, R., Padró, T., Rodrigo Alonso, K., Mata, P., & Badimón, L. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-03-0238 · Cited by 115 · see citing works

Differences in Microparticle Release in Patients With Acute Coronary Syndrome and Stable Angina

Biasucci, L. M., Porto, I., Vito, L. D., Maria, G. L. D., Leone, A. M., Tinelli, G., Tritarelli, A., Rocco, G. D., Snider, F., Capogrossi, M. C., et al. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0068 · Cited by 110 · see citing works

Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease

Mobarrez, F., He, S., Bröijersén, A., Wiklund, B., Antovič, A., Antović, J. P., Egberg, N., Jörneskog, G., & Wallén, H. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-12-0810 · Cited by 101 · see citing works

Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases.

Meziani, F., Tesse, A., & Andriantsitohaina, R. (2008) · PubMed · Cited by 100 · see citing works

Angiotensin II-Induced Mononuclear Leukocyte Interactions with Arteriolar and Venular Endothelium Are Mediated by the Release of Different CC Chemokines

Mateo, T., Nabah, Y. N. A., Abu-Taha, M. I., Mata, M., Cerdá‐Nicolás, M., Proudfoot, A. E. I., Stahl, R. A. K., Issekutz, A. C., Cortijo, J., Morcillo, E. J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5577 · Cited by 98 · see citing works

Microparticles as new markers of cardiovascular risk in diabetes and beyond

Santilli, F., Marchisio, M., Lanuti, P., Boccatonda, A., Miscia, S., & Davı̀, G. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-03-0176 · Cited by 97 · see citing works

Endothelial microparticles as conveyors of information in atherosclerotic disease

Schiro, A., Wilkinson, F. L., Weston, R., Smyth, J. V., Serracino‐Inglott, F., & Alexander, M. Y. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.03.019 · Cited by 96 · see citing works

Increased levels of platelet-derived microparticles in patients with diabetic retinopathy

Ogata, N., Imaizumi, M., Nomura, S., Shozu, A., Arichi, M., Matsuoka, M., & Matsumura, M. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.10.010 · Cited by 81 · see citing works

Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse

Badimón, L., Suades, R., Arderiu, G., Peña, E., Chiva‐Blanch, G., & Padró, T. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00077 · Cited by 80 · see citing works

Cell‐derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?

Baron, M., Boulanger, C. M., Staels, B., & Tailleux, A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01486.x · Cited by 80 · see citing works

Dynamic Role of Microparticles in Type 2 Diabetes Mellitus

Nomura, S. (2009) · Current Diabetes Reviews · doi:10.2174/157339909789804404 · Cited by 78 · see citing works

Vascular complications in diabetes: Microparticles and microparticle associated microRNAs as active players

Alexandru, N., Bădilă, E., Weiss, E., Cochior, D., Stępień, E. Ł., & Georgescu, A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.038 · Cited by 79 · see citing works

Microvesicles and diabetic complications — novel mediators, potential biomarkers and therapeutic targets

Wang, Y., Chen, L., & Liu, M. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.188 · Cited by 74 · see citing works

Microparticles and type 2 diabetes

Leroyer, A. S., Tedgui, A., & Boulanger, C. M. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)70100-9 · Cited by 74 · see citing works

Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus

Nomura, S., Inami, N., Kimura, Y., Omoto, S., Shouzu, A., Nishikawa, M., & Iwasaka, T. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002100 · Cited by 71 · see citing works

Extracellular vesicle signalling in atherosclerosis

Charla, E., Mercer, J. R., Maffia, P., & Nicklin, S. A. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109751 · Cited by 61 · see citing works

Microparticles and cardiovascular diseases

Voukalis, C., Shantsila, E., & Lip, G. Y. H. (2019) · Annals of Medicine · doi:10.1080/07853890.2019.1609076 · Cited by 58 · see citing works

Elevated Levels of Procoagulant Plasma Microvesicles in Dialysis Patients

Burton, J. O., Hamali, H. A., Singh, R., Abbasian, N., PARSONS, R. M., Patel, A. K., Goodall, A. H., & Brunskill, N. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072663 · Cited by 56 · see citing works

Angiotensin II and leukocyte trafficking: New insights for an old vascular mediator. Role of redox-signaling pathways

Piqueras, L., & Sanz, M. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.002 · Cited by 52 · see citing works

Extracellular vesicles in atherothrombosis: From biomarkers and precision medicine to therapeutic targets

Badimón, L., Padró, T., Arderiu, G., Vilahur, G., Borrell-Pagés, M., & Suades, R. (2022) · Immunological Reviews · doi:10.1111/imr.13127 · Cited by 49 · see citing works

Circulating Microparticles as Therapeutic Targets in Cardiovascular Diseases

Azevedo, L. C. P., Pedro, M. D. A., & Laurindo, F. R. M. (2007) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/157489007779606121 · Cited by 47 · see citing works

Novel Biomarkers of Atherosclerotic Vascular Disease—Latest Insights in the Research Field

Adam, C. A., Șalaru, D. L., Prisacariu, C., Marcu, D. T. M., Sascău, R. A., & Stătescu, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094998 · Cited by 49 · see citing works

Angiotensin II induces the generation of procoagulant microparticles by human mononuclear cells via an angiotensin type 2 receptor-mediated pathway

Cordazzo, C., Neri, T., Petrini, S., Lombardi, S., Balìa, C., Cianchetti, S., Carmazzi, Y., Paggiaro, P., Pedrinelli, R., & Celi, A. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.01.019 · Cited by 37 · see citing works

A Single Bout of High-Intensity Interval Exercise Does Not Increase Endothelial or Platelet Microparticles in Stable, Physically Fit Men With Coronary Heart Disease

Guiraud, T., Gayda, M., Juneau, M., Bosquet, L., Meyer, P., Théberge-Julien, G., Galinier, M., Nozza, A., Lambert, J., Rhéaume, É., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.03.024 · Cited by 35 · see citing works

Urinary markers of renal inflammation in adolescents with Type 1 diabetes mellitus and normoalbuminuria

Cherney, D. Z. I., Scholey, J. W., Daneman, D., Dunger, D. B., Dalton, R. N., Moineddin, R., Mahmud, F. H., Dekker, R., Elia, Y. T., Sochett, E. B., et al. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03651.x · Cited by 34 · see citing works

Racial differences in endotoxin-induced tissue factor-triggered coagulation

Mayr, F., Spiel, A. O., Leitner, J. M., Firbas, C., Jilma‐Stohlawetz, P., Chang, J.-Y., Key, N. S., & Jilma, B. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03307.x · Cited by 34 · see citing works

Les microparticules circulantes : rôles physiologiques et implications dans les maladies inflammatoires et thrombotiques

Morel, O., Morel, N., Hugel, B., Jesel, L., Vinzio, S., Goichot, B., Bakouboula, B., Grunebaum, L., Freyssinet, J., & Toti, F. (2005) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2005.03.015 · Cited by 33 · see citing works

Clopidogrel Effectively Suppresses Endothelial Microparticle Generation Induced by Indoxyl Sulfate via Inhibition of the p38 Mitogen-Activated Protein Kinase Pathway

Ryu, J., & Kim, S.-J. (2011) · Blood Purification · doi:10.1159/000326297 · Cited by 31 · see citing works

Increased inflammatory biomarkers in hypertensive type 2 diabetic patients: improvement after angiotensin II type 1 receptor blockade

Touyz, R. M., Savoia, C., He, Y., Endemann, D., Pu, Q., Ko, E. A., Ciuceis, C. D., Montezano, A. C. I., & Schiffrin, E. L. (2007) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2007.01.009 · Cited by 30 · see citing works

Irbesartan administration therapeutically influences circulating endothelial progenitor cell and microparticle mobilization by involvement of pro-inflammatory cytokines

Georgescu, A., Alexandru, N., Nemecz, M., Titorencu, I. D., & Popov, D. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.04.004 · Cited by 29 · see citing works

Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease

Almquist, T., Mobarrez, F., Jacobson, S. H., Wallén, H., & Hjemdahl, P. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv337 · Cited by 29 · see citing works

Extracellular vesicles: Pharmacological modulators of the peripheral and central signals governing obesity

Milbank, E., Martínez, M. C., & Andriantsitohaina, R. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.002 · Cited by 29 · see citing works

Relationship of microparticles to progenitor cells as a measure of vascular health in a diabetic population

Curtis, A. M., Zhang, L., Medenilla, E., Gui, M., Wilkinson, P. F., Hu, E., Giri, J. S., Doraiswamy, V. A., Gunda, S., Burgert, M. E., et al. (2010) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20528 · Cited by 28 · see citing works

Role of extracellular vesicles in atherosclerosis: An update

Coly, P., & Boulanger, C. M. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0221-099r · Cited by 27 · see citing works

Systematic Review and Meta-Analysis of the Effect of Statins on Circulating E-Selectin, L-Selectin, and P-Selectin

Zinellu, A., & Mangoni, A. A. (2021) · Biomedicines · doi:10.3390/biomedicines9111707 · Cited by 27 · see citing works

Microparticules circulantes au cours des traumatismes graves et des sepsis : un élément du couplage inflammation–thrombose

Morel, N., Morel, O., Delabranche, X., Jesel, L., Sztark, F., Dabadie, P., Freyssinet, J., & Toti, F. (2006) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2006.04.013 · Cited by 26 · see citing works

PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH

Baron, M., Leroyer, A. S., Majd, Z., Lalloyer, F., Vallez, E., Bantubungi, K., Chinetti, G., Delerive, P., Boulanger, C. M., Staels, B., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.009 · Cited by 25 · see citing works

Potential role for statins in sickle cell disease

Adam, S. S., & Hoppe, C. C. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24443 · Cited by 19 · see citing works

Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure

Montoro‐García, S., Shantsila, E., Wrigley, B., Tapp, L. D., Alemán, J. A., & Lip, G. Y. H. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2014.11.016 · Cited by 18 · see citing works

Pediatric Statin Administration: Navigating a Frontier with Limited Data

Wagner, J. B., & Abdel‐Rahman, S. M. (2016) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-21.5.380 · Cited by 17 · see citing works

Extracellular vesicles: biomarkers and regulators of vascular function during extracorporeal circulation

McVey, M. J., & Kuebler, W. M. (2018) · Oncotarget · doi:10.18632/oncotarget.26433 · Cited by 17 · see citing works

Extracellular Vesicles as Mediators in Atherosclerotic Cardiovascular Disease

Zisser, L., & Binder, C. J. (2024) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2024.13.3.232 · Cited by 16 · see citing works

Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency

Hamali, H. A., Saboor, M., Dobie, G., Madkhali, A. M., Akhter, M. S., Hakamy, A., Al‐Mekhlafi, H. M., Jackson, D. E., Matari, Y. H., & Mobarki, A. A. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s355395 · Cited by 16 · see citing works

Regulation of capillary tubules and lipid formation in vascular endothelial cells and macrophages via extracellular vesicle-mediated microRNA-4306 transfer

Yang, Y., Luo, H., Zhou, C., Zhang, R., Liu, S., Zhu, X. P., Ke, S., Liu, H., Lu, Z., & Chen, M. (2018) · Journal of International Medical Research · doi:10.1177/0300060518809255 · Cited by 16 · see citing works

Extracellular Vesicles in Essential Hypertension: Hidden Messengers

Salvia, S. L., Gunasekaran, P. M., Byrd, J. B., & Erdbrügger, U. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01084-8 · Cited by 16 · see citing works

Extracellular Vesicles in Diagnosing Chronic Coronary Syndromes the Bumpy Road to Clinical Implementation

Dekker, M., Waissi, F., Timmerman, N., Silvis, M. J. M., Timmers, L., & de Kleijn, D. P. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239128 · Cited by 15 · see citing works

Role of Circulating Microparticles in Type 2 Diabetes Mellitus: Implications for Pathological Clotting

Maphumulo, S. C., & Pretorius, E. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1740150 · Cited by 15 · see citing works

Endothelial Microparticles as Potential Biomarkers in the Assessment of Endothelial Dysfunction in Hypercholesterolemia

Ibrahim, N. N. I. N., Rahman, R. A., Azlan, M., Aziz, A. A., & Rasool, A. H. G. (2022) · Medicina · doi:10.3390/medicina58060824 · Cited by 14 · see citing works

Microparticles in type 2 diabetes mellitus

Davı̀, G., & Ferroni, P. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01196.x · Cited by 13 · see citing works

Marqueurs des pathologies thrombotiques

Morel, O., Toti, F., & Freyssinet, J. (2007) · Annales Pharmaceutiques Françaises · doi:10.1016/s0003-4509(07)90020-6 · Cited by 12 · see citing works

Micropartículas de pequeño tamaño como indicadores del estado agudo en la insuficiencia cardiaca sistólica

Montoro‐García, S., Shantsila, E., Wrigley, B., Tapp, L. D., Alemán, J. A., & Lip, G. Y. H. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.11.020 · Cited by 10 · see citing works

Neutrophil microvesicles and their role in disease

Dow, R., & Ridger, V. C. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106097 · Cited by 9 · see citing works

A systematic review and meta-analysis of the effect of statin treatment on sVCAM-1 and sICAM-1

Zinellu, A., & Mangoni, A. A. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2072294 · Cited by 7 · see citing works

Innovative biomarkers for predicting type 2 diabetes mellitus: relevance to dietary management of frailty in older adults

Ikwuobe, J., Bellary, S., & Griffiths, H. R. (2016) · Biogerontology · doi:10.1007/s10522-016-9634-z · Cited by 7 · see citing works

Pathogenic mechanisms, diagnostic, and therapeutic potential of microvesicles in diabetes and its complications

Abbas, A. A., Almaghrbi, H., Giordo, R., Zayed, H., & Pintus, G. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110168 · Cited by 6 · see citing works

Association between vascular access failure and microparticles in hemodialysis patients

Ryu, J.-H., Lim, S.-Y., Ryu, D., Kang, D., Choi, K. B., & Kim, S.-J. (2012) · Kidney Research and Clinical Practice · doi:10.1016/j.krcp.2011.12.002 · Cited by 6 · see citing works

Unconventional approaches to the prevention of cancer associated thrombosis

Zwicker, J. I. (2014) · Thrombosis Research · doi:10.1016/s0049-3848(14)50008-4 · Cited by 6 · see citing works

Microvesicles as Biomarkers in Diabetes, Obesity and Non-Alcoholic Fatty Liver Disease: Current Knowledge and Future Directions

Welsh, J. A. (2014) · Internal Medicine Open Access · doi:10.4172/2165-8048.s6-009 · Cited by 4 · see citing works

Differential and targeted vesiculation: pathologic cellular responses to elevated arterial pressure

Brown, P. A. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04351-7 · Cited by 4 · see citing works

Two genetic variants in the promoter region of the CCL5 gene are associated with the risk of acute coronary syndrome and with a lower plasma CCL5 concentration

Herrera‐Maya, G., Vargas‐Alarcón, G., Ramírez‐Bello, J., Pérez-Méndez, O. A., Posadas‐Sánchez, R., López‐Marure, R., Granados, J., Nieto-Lima, B., & Fragoso, J. M. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.10.006 · Cited by 2 · see citing works

Application of angiotensin ii to healthy rat sciatic nerve can produce neuropathy without associated vasculopathy

Kasselman, L. J., & Rutkove, S. B. (2010) · Muscle & Nerve · doi:10.1002/mus.21767 · Cited by 1 · see citing works

Comparison of the efficacy and safety of an oral combination of losartan, hydrochlorothiazide and simvastatin against separated components, in hypertensive and dyslipidemic patients

Murad, E. E., Luis, F., o, P. F. N., Jorge, A. A. V., Elvira, I. N. O. C., Juan, G. R. G. A., Francisco, J. F. M., Miriam, D. C. C. P., & Noemiacute, S. C. (2015) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp2014.4217 · Cited by 1 · see citing works

Microparticles and Exosomes in Cell-Cell Communication

Rios, F. J. O., Touyz, R. M., Montezano, A. C. I., & Burger, D. E. (2019) · Springer eBooks · doi:10.1007/978-3-030-16481-2_15 · Cited by 1 · see citing works

Platelet activation marker

Nomura, S. (2007) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.18.597

Novel biomarkers in vascular remodelling and inflammation in pulmonary arterial hypertension

Gurung, R. (2016) · UCL Discovery (University College London)

Extracellular Vesicles for risk stratification in coronary artery disease

Dekker, M. (2022) · doi:10.33540/945

Microparticules : de la génération de plasmine à la standardisation d'un biomarqueur émergeant

Lacroix, R. (2010) · doi:10.70675/561035e7ze967z47edz9b31z107b5d94b257

Losartan and Simvastatin Inhibit Platelet Activation in Hypertensive Patients

Nomura, S., Shouzu, A., Omoto, S., Nishikawa, M., Fukuhara, S., & Iwasaka, T. (2004) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-005-0343-8 · Cited by 61 · see citing works

Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus

Nomura, S., Shouzu, A., Omoto, S., Nishikawa, M., Fukuhara, S., & Iwasaka, T. (2005) · Thrombosis Research · doi:10.1016/j.thromres.2005.04.008 · Cited by 84 · see citing works

Vascular and Metabolic Effects of Combined Therapy With Ramipril and Simvastatin in Patients With Type 2 Diabetes

Koh, K. K., Quon, M. J., Han, S. H., Ahn, J. Y., Jin, D., Kim, H. S., Kim, D. S., & Shin, E. K. (2005) · Hypertension · doi:10.1161/01.hyp.0000166722.91714.ba · Cited by 153 · see citing works

Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment

Marino, F., Maresca, A. M., Cosentino, M., Castiglioni, L., Rasini, E., Mongiardi, C., Maio, R. C., Legnaro, M., Schembri, L., Dentali, F., et al. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-153 · Cited by 11 · see citing works

Microparticles and hypertensive cardiovascular disease:effects of anti-hypertensive and lipid-lowering therapy on circulating microparticles

Izar, M. C. D. O., França, C. N., Matsunaga, N. D., Ferreira, C. E. S., Bianco, H. T., Kato, J. T., do Amaral, J. B., & Fonseca, F. A. H. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.640